Organamin contains Lithothamnium calcareum, a naturally mineral-rich red marine algae. Each daily serving of two capsules provides 800 mg of calcium, 80 mg of magnesium and naturally occurring trace minerals, making Organamin a broad-spectrum source of marine-derived minerals.
What makes Lithothamnium particularly interesting is that the algae naturally concentrates minerals from seawater within its calcareous structure. Scientific research has investigated these minerals in human studies, particularly in relation to calcium metabolism, bone health and joint comfort.
In a double-blind clinical trial involving 12 premenopausal women, calcium derived from Lithothamnium produced a greater urinary calcium response and a more prolonged suppression of parathyroid hormone (PTH) compared with placebo. The researchers concluded that the preparation influenced markers of calcium metabolism.
A 24-month randomized, double-blind study involving 300 postmenopausal women investigated a calcium-rich marine multi-mineral preparation derived from Lithothamnium. Researchers observed changes in markers of bone turnover, while an exploratory analysis found that women with osteopenia receiving the preparation together with a prebiotic had less decline in certain bone-density measurements. Importantly, the overall study did not find a significant difference in bone mineral density between all treatment groups.
Other human research has investigated Lithothamnium-derived mineral preparations in people with knee osteoarthritis, reporting improvements in pain and physical function in a small randomized pilot study.
Organamin provides this naturally occurring marine mineral profile in a convenient daily supplement - bringing together calcium, magnesium and trace minerals from their natural marine source.
This information describes research on Lithothamnium-derived mineral preparations and should not be interpreted as clinical evidence that Organamin treats or prevents disease.
References
- Zenk JL, Frestedt JL, Kuskowski MA. Effect of Calcium Derived from Lithothamnion sp. on Markers of Calcium Metabolism in Premenopausal Women. Journal of Medicinal Food. 2018;21(2):154–158.
- Slevin MM, et al. Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women. The Journal of Nutrition. 2014;144(3):297–304.
- Heffernan SM, et al. Mineral rich algae with pine bark improved pain, physical function and analgesic use in mild-knee joint osteoarthritis. Complementary Therapies in Medicine. 2020;50:102349.
- Aslam MN, et al. A Calcium-Rich Multimineral Intervention to Modulate Colonic Microbial Communities and Metabolomic Profiles in Humans. Cancer Prevention Research. 2020;13:101–116.
